Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease
Abstract Background Chronic alcohol consumption is a significant cause of liver disease worldwide. Several biochemical mechanisms have been linked to the initiation and progression of alcoholic liver disease (ALD) such as oxidative stress, inflammation, and metabolic dysregulation, including the dis...
Main Authors: | Mohammed A. Assiri, Hadi R. Ali, John O. Marentette, Youngho Yun, Juan Liu, Matthew D. Hirschey, Laura M. Saba, Peter S. Harris, Kristofer S. Fritz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40246-019-0251-1 |
Similar Items
-
Nicotinamide Mononucleotide (NMN) Works in Type 2 Diabetes through Unexpected Effects in Adipose Tissue, Not by Mitochondrial Biogenesis
by: Roua Gabriela Popescu, et al.
Published: (2024-02-01) -
Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
by: Chidambaram Ramanathan, et al.
Published: (2022-01-01) -
Determination of β-Nicotinamide Mononucleotide (NMN) in NMN Cross Border Products
by: Wenyu ZHANG, et al.
Published: (2022-05-01) -
Effects of β-Nicotinamide Mononucleotide, Berberine, and Cordycepin on Lipid Droplet Content and Developmental Ability of Vitrified Bovine Oocytes
by: Xi Xu, et al.
Published: (2023-04-01) -
Improvement of tissue‐specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol
by: Long‐Bo Bai, et al.
Published: (2022-08-01)